Modulation of liver tolerance by conventional and nonconventional antigen-presenting cells and regulatory immune cells

AK Horst, K Neumann, L Diehl, G Tiegs - Cellular & molecular …, 2016 - nature.com
The liver is a tolerogenic organ with exquisite mechanisms of immune regulation that ensure
upkeep of local and systemic immune tolerance to self and foreign antigens, but that is also …

Liver metastases: Microenvironments and ex-vivo models

AM Clark, B Ma, DL Taylor, L Griffith… - … Biology and Medicine, 2016 - journals.sagepub.com
The liver is a highly metastasis-permissive organ, tumor seeding of which usually portends
mortality. Its unique and diverse architectural and cellular composition enable the liver to …

Integrins and heparan sulfate proteoglycans on hepatic stellate cells (HSC) are novel receptors for HSC‐derived exosomes

L Chen, DR Brigstock - FEBS letters, 2016 - Wiley Online Library
Exosomes mediate intercellular microRNA delivery between hepatic stellate cells (HSC), the
principal fibrosis‐producing cells in the liver. The purpose of this study was to identify …

[HTML][HTML] Activated hepatic stellate cells promote liver cancer by induction of myeloid-derived suppressor cells through cyclooxygenase-2

Y Xu, W Zhao, J Xu, J Li, Z Hong, Z Yin, X Wang - Oncotarget, 2016 - ncbi.nlm.nih.gov
Hepatic stellate cells (HSCs) are critical mediators of immunosuppression and the
pathogenesis of hepatocellular carcinoma (HCC). Our previous work indicates that HSCs …

[HTML][HTML] MiRNA-22 inhibits oncogene galectin-1 in hepatocellular carcinoma

Y You, JX Tan, HS Dai, HW Chen, XJ Xu, AG Yang… - Oncotarget, 2016 - ncbi.nlm.nih.gov
Hepatic stellate cells (HSCs) induce immune privilege and promote hepatocellular
carcinoma (HCC) by suppressing the immune system. On the other hand, galectin-1 and …

[HTML][HTML] Follicular helper T cell exhaustion induced by PD-L1 expression in hepatocellular carcinoma results in impaired cytokine expression and B cell help, and is …

ZQ Zhou, DN Tong, J Guan, HW Tan… - American Journal of …, 2016 - ncbi.nlm.nih.gov
Hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) is one of the most common
cancers in HBV-endemic regions, with irreversible progression and poor prognosis. HBV …

Hepatic Stellate Cells Directly Inhibit B Cells via Programmed Death–Ligand 1

Y Li, L Lu, S Qian, JJ Fung, F Lin - The Journal of Immunology, 2016 - journals.aai.org
We demonstrated previously that mouse hepatic stellate cells (HSCs) suppress T cells via
programmed death–ligand 1 (PD-L1), but it remains unknown whether they exert any effects …

Accessory cells for β‐cell transplantation

W Staels, S De Groef, Y Heremans… - Diabetes, Obesity …, 2016 - Wiley Online Library
Despite recent advances, insulin therapy remains a treatment, not a cure, for diabetes
mellitus with persistent risk of glycaemic alterations and life‐threatening complications …

The CD8 T‐cell response during tolerance induction in liver transplantation

YC Wong, GW McCaughan, DG Bowen… - Clinical & …, 2016 - Wiley Online Library
Both experimental and clinical studies have shown that the liver possesses unique
tolerogenic properties. Liver allografts can be spontaneously accepted across complete …

Transcriptomic analysis of the effects of Toll-like receptor 4 and its ligands on the gene expression network of hepatic stellate cells

Y Ouyang, J Guo, C Lin, J Lin, Y Cao, Y Zhang… - Fibrogenesis & tissue …, 2016 - Springer
Abstract Background Intact Toll-like receptor 4 (TLR4) has been identified in hepatic stellate
cells (HSCs), the primary fibrogenic cell type in liver. Here, we investigated the impact of …